CompletedPhase 2/3

Efficacy of Probiotics in the Gut Microbiota and H Pylori Density

Taiwan40 participantsStarted 2016-03

Plain-language summary

We aimed to assess the efficacy of Lactobacillus acidophilus and Lactobacillus rhamnosus in the reduction of bacterial load of H. pylori and in the modification of gut microbiotia in this double blind, placebo controlled, randomized trial.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult subjects aged 20 or greater with moderate to high bacterial load of H. pylori defined as a DOB value greater than 10 will be eligible to this trial Exclusion Criteria: * history of gastrectomy and colectomy * severe underlying illness, such as malignancy, ESRD, liver failure, etc * allergy to probiotics * symptomatic patients who need PPI, antibiotics, or other probiotics * pregnancy and lactating women * unable to cooperate with the protocol

What they're measuring

Reduction of bacterial load of H. pylori

Timeframe: after 4 weeks of treatment

Trial details

NCT IDNCT02725138

SponsorStatistical Center, NTUHCTC

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-01

View on ClinicalTrials.gov More Helicobacter trials